| Claris Lifesciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2021 | Mar '2020 | Mar '2019 | Mar '2018 | Mar '2017 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 |
| Long Term Debt-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 |
| Current Ratio | 0.41 | 0.49 | 0.64 | 3.27 | 3.23 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debtors | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Cover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBITM (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDTM (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CPM (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| APATM (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| ROCE (%) | 0.00 | 0.00 | 0.00 | -2.87 | 0.19 |
| RONW (%) | 0.00 | 0.00 | 0.00 | 1.88 | 0.27 |